Blocking Tim-3 signaling also increased the proliferation of tumor-infiltrating T cells in HBV-associated HCC patients, and the number of Tim-3+ tumor-infiltrating cells was negatively link with patients’ survival [111]. The gene discussed is HAVCR2; the disease is hepatocellular carcinoma.